Report #2825417

Received Feb 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 66 yrs
State: GA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	D5AP5	IM / LA

Symptoms (2)

Product administered to patient of inappropriate ageProduct preparation issue

Symptom narrative

patient was administered 2 vials of adjuvant and no powder (Antigen); patient was administered 2 vials of adjuvant and no powder (Antigen); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number D5AP5, expiry date 31-AUG-2026) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, left deltoid). On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered 2 vials of adjuvant and no powder (Antigen)) and inappropriate dose of vaccine administered (Verbatim: patient was administered 2 vials of adjuvant and no powder (Antigen)). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 21-JAN-2025 The pharmacist reported that the patient was administered 2 vials of adjuvant and no powder (Antigen) which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. There had been no complaints of any effects.